Creatine Kinase-MB (CKMB)
Creatine kinase isoenzymes are an enzyme component, among which MB type is mainly present in myocardial cells. It is also a kind ofcardiac marker.
CK MB proteinis of great significance in clinical diagnosis. The serum creatine kinase level increases rapidly in various diseases, including muscular atrophy and myocardial infarction. The determination of creatine kinase activity is more reliable than electrocardiogram in the diagnosis of myocardial infarction. In myocardial infarction, creatine kinase increased within six h of onset, peaked at 24 h, and returned to normal within 3-4 days.
The isoenzyme CK-MB of creatine kinase has the highest specificity in diagnosis. Creatine kinase has attracted extensive attention and in-depth research because of its essential physiological function and clinical application value.
SEKBIOprovides related detection raw materials: Mouse anti-human CKMB mAb and Humanized anti-human CKMB mAb.
What is Creatine Kinase MB?
The creatine kinase molecule is a dimer consisting of a brain-type subunit (B) and a muscle-type subunit (M). Normal human tissues often contain three isoenzymes, which are CK-BB (CK1), CK-MB (CK2), and CK-MM (CK3) in the order of electrophoresis. CK-MB protein mainly exists in myocardial tissue, accounting for 0-4% of CK in serum. CK and CK-MB are sensitive indicators of myocardial tissue damage, especially CK-MB is more specific. The increase of creatine kinase mb antibodymainly causes the growth of CK during myocardial injury.
CK-MB Protein
Creatine kinase is one of the essential indicators of laboratory tests. When the myocardial tissue is seriously damaged, CK-MB is released into the blood, and the serum CK-MB protein becomes a vital criterion for diagnosing acute myocardial infarction.
Increased serum ck ckmbprotein is common in acute myocardial infarction, skeletal muscle injury, trauma, strenuous exercise, etc. Serum CK-MB can also be increased in malignant fever patients and some members of their families. In patients with rhabdomyosarcoma, serum CK-MB protein can be significantly increased. In addition, cardiac surgery that damages the myocardium may have a transient increase in CK-MB, which usually returns to normal within 24 hours after surgery.
Sekbioprovide creatine kinase mb test, cpk mb test, cpk mb blood test, ckmb blood test, ivd antibodyand etc. Want to more, contact us.
在线联系供应商
Other supplier products
 |
Mouse Anti-human ProGRP mAb | Pprogrp antibody Name: Mouse anti-human ProGRP mAb Catalog No.: ZLA116-1M Description: Mouse mAb Epitope: 48-52 As a professional tumor marker... |
 |
Squamous Cell Carcinoma (SCC) | Squamous cell carcinoma (SCC Tumor Marker) antigen is a 48kDa glycoprotein initially isolated from a squamous cancer of the uterine cervix. Immuno... |
 |
CA50 Tumor Marker | CA50 is a kind of sialic acid ester and sialic acid glycoprotein, which generally does not exist in normal tissues. When cells become malignant, gl... |
 |
Thyroglobulin (Tg) | Thyroid thyroglobulinis a 660 kDa, a dimeric glycoprotein produced by the follicular cells of the thyroid and released into the residual cavity of ... |
 |
Triiodothyronine (T3) | Triiodothyronine, also known as T3, is a thyroid hormone. It affects almost every physiological process in the body, including growth and developme... |
Same products
|
|
Creatine Kinase-MB (CKMB) | 卖方: Shenzhen SEKBIO Co., Ltd | Creatine kinase isoenzymes are an enzyme component, among which MB type is mainly present in myoc... |
 |
C-Reaction Protein (CRP) | 卖方: Shenzhen SEKBIO Co., Ltd | C-reactive protein (CRP) refers to several proteins (acute proteins) that rise sharply in blood p... |
 |
Cardiac Troponin I (cTnI) | 卖方: Shenzhen SEKBIO Co., Ltd | Cardiac troponin I, often denoted as cTnI, is presented in cardiac muscle tissue by a single isof... |
 |
CA50 Tumor Marker | 卖方: Shenzhen SEKBIO Co., Ltd | CA50 is a kind of sialic acid ester and sialic acid glycoprotein, which generally does not exist ... |
 |
CA242 Tumor Marker | 卖方: Shenzhen SEKBIO Co., Ltd | CA242, or Cancer Antigen 242, is a notable glycoprotein biomarker within the realm of oncology an... |
